Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2026 for CRISPR Therapeutics AG, €106k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
James Kasinger: trading record in brief
James Kasinger is a declared insider of CRISPR Therapeutics AG, with filings sourced from SEC (Form 4). Between 22 September 2026 and 6 October 2026, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 6 October 2026, the filings show a transaction worth €106k in CRISPR Therapeutics AG. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Kasinger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,990 shares@ US$60.0408CommonSEC144:0001950047-26-010087
10,400 shares@ US$60.23650.012% mcap100.0% of flowCommonSEC144:0001950047-26-009755
2 of 2 declarations
